The Case for Hiring an Investment Bank: Adding Value to Your Value Proposition – MedCity News

[ad_1] You’ve probably heard the term “investment banker” at some point, but unless you are in the financial services industry or hold a specific role that may have occasion or…

A Paradigm Shift Towards Reimbursing the Root Causes of Diseases – MedCity News

[ad_1] Research shows that sixty to eighty percent of population health outcomes are driven by non-clinical factors, mainly social determinants of health (SDoH). SDoH includes the environmental factors that affect…

Why Provider Groups Are Denouncing CMS’ New Payment Rules – MedCity News

[ad_1] This week, the Centers for Medicare & Medicaid Services finalized updates to its physician fee schedule for 2024, as well as finalized the rule for next year’s Outpatient Prospective…

Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation – MedCity News

[ad_1] The inflamed, red skin characteristic of atopic dermatitis develops and worsens in a vicious cycle. Itching leads to scratching, which leads to more itching. The immune response to all…

Pioneering operation combines cancer surgery and Caesarean

[ad_1] Four women have had a landmark two-in-one operation to reduce the inherited risk of ovarian cancer. [ad_2] Source link

Unlocking the Power of Healthcare Audiences: Segmenting Stakeholders and Maximizing Impact – MedCity News

[ad_1] In today’s rapidly evolving healthcare landscape, developing strong core brand strategies is crucial for successful marketing campaigns within the healthcare and med-tech industries. The diverse group of stakeholders that…

Revamping HHS’ Complex Organizational Structure Could Improve Its Performance During Public Health Emergencies – MedCity News

[ad_1] “We shape our buildings,” Winston Churchill once said, “and afterwards our buildings shape us.” The same could be said of an organization’s structure and its ongoing impact on members…

Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

[ad_1] SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory…

How KelaHealth Slashed the Rate of Post-Surgical Complications at Duke – MedCity News

[ad_1] The digital health market is full of companies promising to transform healthcare, but investors and health systems are finally demanding to see evidence from startups that actually prove their tech’s…

Why Physicians in ACOs Are Happier With Their Compensation – MedCity News

[ad_1] Only 21% of primary care physicians feel they are fairly compensated, according to a new report released by Pearl Health, a tech company that helps independent physician practices participate…